Objective: To describe trends in the prevalence of HIV-1 infection in different populations in Gabon, and the molecular characteristics of circulating HIV strains.
Introduction
The course of the HIV/AIDS epidemic has shown wide variations between different regions in sub-Saharan Africa. In some Central African towns, such as Kinshasa (Zaïre), HIV prevalence among pregnant women has remained relatively low and stable since the nlid-l980s, but in othg large towns, such as Kampala (Uganda), Lusaka (Zambia) and Blantyre (Malawi), the epidemic has been explosive with HIV prevalence levels in pregnant women now well above 20% [1, 2] . In all regions of sub-Saharan Mica the predominant mode of HIV transmission is through sexual intercourse between men and women. The reasons for the heterogeneity in the spread of HIV infection are poorly understood. Various factors can influence the efficiency of sexual transmission and can therefore play a role in the dynamics of HIV infection: patterns of risk behaviour, the incidence of other sexually transmitted diseases (STD), several demographic variables, and circumcision, which is considered a major factor [l-51. The efficiency of HIV transmission can depend on biological factors: viral load, during early and large stages of the infection, may be raised severalfold [6].
The role of Werent HIV strains in the dynamics of the HIV epidemic remains the subject of controversy. There are strong suggestions that HIV-1 is more transmissible than HIV-2, which would explain why HIV-2 remains less prevalent than HIV-1 [7] . In terms of HIV-1 subtypes, recent data fiom Thailand suggest that HIV-1 subtype E may be more easily transmitted through heterose.wal contact than HIV-1 subtype B [SI. There are two main groups of HIV-1, as determined by phylogenetic analysis of geographically divergent isolates: group M and group O. Group M, the major group, comprises at least nine different genetic subtypes (A to I) [9] , all of which have been described in African patients. HIV-1 group O viruses are highly divergent HIV-1 viruses and have so far been found mainly in Cameroon or people fi-om Cameroon living in France [10, 11] .
Our knowledge on the geographical distribution of the different HIV-1 genotypes in Africa is incomplete, but the few data that are available suggest that the relative prevalence of each genotype differs from region to region [12] . It has been suggested that these differences in the distribution of HIV-1 subtypes could explain, at least in part, the wide variations in the-_course.pf the HIT? epidemic in sub-Saharan Africa. [16, 17] were origindy found in Gabon. These observations have led to speculation on the origins and evolution of HIV viruses in this part of the world. 
Materials and methods

Study population
Gabon is.situated in Western Equatorial Africa and has a population of about 1.2 million inhabitants. During the last decade, the population of Gabon became mainly urban. In Libreville, the capital city, the population ranged fiom 200 O00 inhabitants in 1980 to 450 O00 inhabitants in 1994; 75% of the population lives in urban areas. A high number of immigrants (about 200 000) are h i n g in the main towns of Gabon, mostly h m neighbouring countries and West Mica.
Data were collected on HIV prevalence through planned random surveys in different populations in Libreville and Francede, which is situated in a semi-rural area in the south-eastern part of the country. In Libreville, a random selection of patients admitted to the Infectious Diseases Department of the General Hospital was tested each year fi-om 1988 to 1994 (n = 864); random samples of tuberculosis patients were screened between 1990 and 1994 (n = 177). Sentinel surveillance among pregnant women attending antenatal clinics around Libreville provided prevalence data for 1988,1993 and 1994 (n = 2753) . In addition, in each of the years 1986, 1988 and 1989 a population-based survey was carried out on HIV prevalence among adults (n = 1180).
The methods of these surveys are described in more detail elsewhere [13, 18] . In each of these surveys between 350 and 400 adults in the age group 15-49 years were randomly selected &om the general population by two-stage cluster sampling [13, 18] . In 1986 and 1994 a survey among prisoners (n = 1808) was also carried out. In Franceville, data were collected on pregnant women in 1986 and 1987 (n = 771), and general population surveys were carried out in 1986 and 1988 (n = 886). [20] . Sera were screened by an improved ELISA using V3 peptides from H I V -~A N T -~, and HIV-lMvp-5 180 followed by confirmation by LIA where different biotinylated V3 peptides from various HIV-1 strains (consensus peptide, Mn, Mal, Eli, ANT-70, MVP-5180 and SIVcpz-gab) were applied as a streptavidin complex in parallel lines on nylon strips. The V3 ELISA and LIA were research products kindly provided by Innogenetics. ELISA-reactive sera were also retested in the in-house HIV-1 ANT-70 Western blot. Western blot strips were prepared as previously described [21] . Sera were considered as having antibodies to HIV-1 group O if they showed a strong and specific reaction with the ANT-70 or MVP-5180 peptide on LIA, and if they have also antibodies to the a l 2 0 of HIV-~ANT-~, on Western blot.
HIV serology
Genetic analysis
A total of 17 virus strains were isolated between 1988 and 1993, as previously described [22] ; 10 strains were from Librede. Of these 10 strains, four were isolated from asymptomatic seropositive persons identified in the general population survey of 1988 (LBV2-3, LBV10-5, LBV21-7, LBV23-10); six were collected between 1989 and 1993 from AIDS patients admitted to the Infectious Diseases Department of the General Hospital (VI685 in 1992 , VI1686 in 1992 , VI1076 in 1993 ,.-VI525.in 1990 , VI526 in 1990 , VI354 in 1989 . The'seveqjremaining strains (G41, G98, G109, G134, G13Sj G139, G141) were isolated from AIDS patients living in. F:,pcevdle and were collected between 1988 and 1989; ALI 17 persons were from Gabon, except for one man who was from Niger (strain G98 
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Preparation of DNA template for polymerase chain reaction (PCK) was perfornied as described elsewhere [22] . A nested PCR was performed in 50 pl reaction mixture containing 50 niniol/l KCI; 10 mniol/l TrisHCl (pH 8.3); 2.5 mmol/l MgCl,; 0.01% gelatin; 0.2 mniol/l deoxyribonucleotides (dATP, dCTP, dGTP, dTTP); 0.4 pmolll of each primer and 1.25 U Taq DNA polymerase (Perkin-Elmer Cetus, Zaventem, Belgium). Restriction sites were added to the 5' end of the primers for cloning purposes. An aliquot corresponding to 1 pg DNA was subjected to a first PCR round of 35 cycles. Gabonese isolates were amplified as previously described [23] except for strains LBV10-5, G134, G139 and G141 which were amplified with the outer primers WOU26andWOU29 (WOU26:j '-GCATCTCCTATG GCAGGAAGAAG-3'; WOU29: 5 '-TGTAAGTCATT GGTCTTAAAGGTACCTG-3 ') . Cycling conditions were 1 min at 94"C, 1 min at 50°C and 5 min at 72°C in a thermal DNA cycler (Perkin-Elmer Cetus). Two microlitres of the amplified DNA were subjected to a second round of 25 cycles using the inner primers JFES and WOU28 (JFES: 5 '-CgctgaattcAGAGCAGAAGAC
CACCACTTGCCACCCAT-3'). Cycling conditions were 1 min at 94"C, 1 min at 55°C and 5 min at 72°C.
PCR fragments were digested with their respective restriction enzymes, electrophoresed on a 1% agarose gel, purified, ligated into a pUC18 or pBR322 cloning vector and introduced in Escherichia colì. One clone was sequenced for each isolate. Purified plasmid DNA (Qiagen plasmid kit; Westburg, Leiden, The Netherlands) was used as template and sequencing reactions were performed. Electrophoresis and data collection were done on a Pharmacia automated laser fluorescence sequencer. Sequences were always obtained for both DNA strands and additional sequencing was performed in case of unsolved ambiguities.
The 17 Gabonese HIV env sequences were aligned with 29 previously known sequences of HIV-1 isolates of diverse geographical origin and the SIVcpz-gab sequence on the basis of primary structure. The previously reported HIV-1 sequences are of the strains, LAI, MN, SF2, D687, U455, OYI, 2321, NDK, 2226, ELI, D747, NOF, CA13, VI557, BZ126, BZ163, LBV21-7, V1525, C213, C122, CA4, CA5, CA10, CA16, CA20, CM239, CM235, MVP5180, VAU and ANT-70.
The nucleotide sequence data were deposited in the European Molecular Biology Laboratory, GenJ3ank and DNA !bata Bank of Japan Nucleotide Sequence Databases under the following accession numbers. (X90912 to X90924 and X96526). (x' for trend, 19.05; P = lo-'). Among the tuberculosis patients, the HIV seroprevalence increased from 1.5% in 1990 to 16.2% in 1994 ( x ' for trend, 25.47; P = lo-').
Statistical analysis
HIV prevalence in the different population groups Table 1 shows the prevalence data for the groups in different years. In Libreville, the HIV prevalence among pregnant women ranged between 0.7 and 2.2% from 1988 to 1994, without evidence of a significant increase over this 6-year time period. Similarly, the HIV prevalence in the general population remained relatively low and stable between 1986 and 1989, ranging between 1.7 and 2.2%. The prevalence among 1158 prisoners tested in 1994 was nearly the same as the prevalence among 650 prisoners tested in 1986 (2.1 versus 2.7%). The prevalence data fiom Franceville also show low levels of infection in the general population. In l9BG and 1987 the HIV infection rates among pr&$antiwomen were 0.8 and 1.3%, respectively. The @neral population surveys gave levels of 0.3 and 0.8% in 4'886 and 1988, Among patients admitted to the Infectious Diseases Department and among tuberculosis patients higher HIV prevalences were found than in the generai population, as expected. There & also a marked increase of the prevalence in these groups of patients between 1988 and .I.\ '5 respectively.
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Of the 226 sera which were HIV-positive, 218 (96.5%) were with HIV-1-positive and only eight (3.5%) were HIV-2-positive.
HIV-1 group O antibodies
A total of 1089 sera were tested for the presence of antibodies to group O viruses ( Table 3) . Of these, 185 HIVpositive sera were collected in epidemiological surveys. Only two of these sera were found to be positive for HIV-1 group O, one was &om a patient admitted to the Infectious Disease Department in Libreville, in 1992, the other was tiom a pregnant woman attending an antenatal clinic in 1993. Both women were Gabonese. In Librevillt, 205 HIV-1-positive and 79 indeterminate sera, collected beciveen 1992 and 1994 from the blood bank and the national laboratory, were negative for group O antibodies. In Franceville, one out of the 272 HIV-1-positive sera fiom CIRM was positive for antibodies to group O, but none of the 226 indeterminate and 62 ELISApositive but Western blot-negative sera had group O antibodies. The relative fiequency of HIV-1 group O 
Genetic analysis
The sequence diversity of a 900 base-pair fragment encoding part of the env region containing V3, V4 and V5 and the beginning of gp41 was studied, and a phylogenetic tree was constructed based on 872 unambiguously aligned positions. The 17 Gabonese HIV-1 strains represent six different genetic subtypes. In the tree (Fig.  1) (VI685, G41, G135,LBV2-3, G139,VI1076, LBV23-10)
, . .
Discussion
The prevalence data of the pregnant women and the results of the repeated population surveys indicate that between 1986 and 1994 the prevalence of HIV infection in the general population of Libreville remained relatively low and stable. However the time span for which data are available is too short to allow us to draw any firm conclusions as to the future course of the HIV epidemic in Gabon. At this stage it is impossible to say whether prevalence levels will remain low or whether the epidemic in Gabon is still in its earlier stages and the prevalence data represent datapoints on the low end of an exponential curve which will rise sharply in the next few years. However, the increase in HIV prevalence among patients admitted to the Infectious Diseases Department and among tuberculosis patients suggests that the HIV epidemjc in Gabon is s d in its early stages and may not yet ha4e reaclied a plateau.
Although the results &om the epidemiological studies suggest a relatively recent start of the epidemic in Libreville, the genetic characteristics of the circulating virus strains suggest that HIV viruses have been circulating in Gabon for a very long time. Our sample size of 17 HIVpositive isolates is rather small, yet we were able to document the presence of at least five Merent group M sub- 
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,:. for which the country code is indicated: and the simian immunodeficiency virus (SIVkpz-gab. The sequences determined in this study are indicated in bold type. The distance between two sequences is obtained by summing the lengths of the connecting branches using the scale at the top. The number of bootstrap trees out of 1 O00 replications supporting a particular phylogenetic group in more than 75% is placed alongside the node considered.
types as well as one group O subtype. A similar large subtypes A, B, E, F and H are circulating, as well as group variety of HIV-1 subtypes has been found in Cameroon O viruses [35] . In the Central African Republic, subtypes and the Central African Republic [24] . In Cameroon,
A, C, D, E, G and H have been found. The large variety Gabon, 1986 Gabon, -1994 were positive for syphilis [32] . These data indicate high levels of high-risk sexual behaviour. However, we do not have any data on sexual behaviour patterns, more specifically sexual mixing patterns and concurrent partnerships, which have been suggested as critical determinants of the rate of spread of HIV infection in populations [33] . These sexual patterns and concurrent partnerships, as well as circumcision status of the male partner, might be an important determinant in explaining the differences in the course of the HIV epidemic between different parts of Africa. In Gabon, circumcision is commonly practised on men, and this factor is believed to be a protective factor against the spread of HIV infection. Other factors related to the efficiency of virus transmission include sexual practises such as intercourse during menses or anal intercourse; the presence of another STD; condom use; and disease stage of the infected partner.
Other potential factors involved in the spread of the HIV infection could be related to demographic variables and genetic characteristics of the virus or the population, or both. In countries where the epidemic is spreading dramatically, a massive migration of rural inhabitants to urban centres has been fiequently observed [34] , but in Gabon, at least at present, rapid urbanization is not associated with rapid spread of HIV infection.
The genetic subtype of the virus can also be a factor in the difference of the HIV spread [10, 11] Finally, human leukocyte antigen characteristics and natural resistance to HIV of some populations is a potential factor which has to be considered but for which no data are currently available.
AIDS 1996,Vol 10 N o 8 I i A better understanding of the reasons for the differences in spread of HIV infection is urgently needed for the design of more cost-effective interventions to control the spread of HIV infection, and'would rhus enable more accurate predictions of the future spread of HIV infection.
